XLV vs. IBB
Compare and contrast key facts about Health Care Select Sector SPDR Fund (XLV) and iShares Nasdaq Biotechnology ETF (IBB).
XLV and IBB are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. XLV is a passively managed fund by State Street that tracks the performance of the Health Care Select Sector. It was launched on Dec 16, 1998. IBB is a passively managed fund by iShares that tracks the performance of the NASDAQ Biotechnology Index. It was launched on Feb 5, 2001. Both XLV and IBB are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: XLV or IBB.
Key characteristics
| XLV | IBB | |
|---|---|---|
| YTD Return | 3.64% | -2.04% |
| 1Y Return | 8.11% | 2.36% |
| 3Y Return (Ann) | 6.31% | -3.74% |
| 5Y Return (Ann) | 11.24% | 4.55% |
| 10Y Return (Ann) | 11.15% | 5.93% |
| Sharpe Ratio | 0.69 | 0.12 |
| Daily Std Dev | 10.53% | 16.73% |
| Max Drawdown | -39.18% | -62.85% |
| Current Drawdown | -4.67% | -23.94% |
Correlation
The correlation between XLV and IBB is 0.73, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
XLV vs. IBB - Performance Comparison
In the year-to-date period, XLV achieves a 3.64% return, which is significantly higher than IBB's -2.04% return. Over the past 10 years, XLV has outperformed IBB with an annualized return of 11.15%, while IBB has yielded a comparatively lower 5.93% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
XLV vs. IBB - Expense Ratio Comparison
XLV has a 0.12% expense ratio, which is lower than IBB's 0.47% expense ratio.
Risk-Adjusted Performance
XLV vs. IBB - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Health Care Select Sector SPDR Fund (XLV) and iShares Nasdaq Biotechnology ETF (IBB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
XLV vs. IBB - Dividend Comparison
XLV's dividend yield for the trailing twelve months is around 1.56%, more than IBB's 0.31% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
XLV Health Care Select Sector SPDR Fund | 1.56% | 1.59% | 1.47% | 1.33% | 1.49% | 2.16% | 1.56% | 1.46% | 1.59% | 1.43% | 1.34% | 1.51% |
IBB iShares Nasdaq Biotechnology ETF | 0.31% | 0.26% | 0.31% | 0.21% | 0.21% | 0.17% | 0.20% | 0.30% | 0.19% | 0.03% | 0.15% | 0.03% |
Drawdowns
XLV vs. IBB - Drawdown Comparison
The maximum XLV drawdown since its inception was -39.18%, smaller than the maximum IBB drawdown of -62.85%. Use the drawdown chart below to compare losses from any high point for XLV and IBB. For additional features, visit the drawdowns tool.
Volatility
XLV vs. IBB - Volatility Comparison
The current volatility for Health Care Select Sector SPDR Fund (XLV) is 2.83%, while iShares Nasdaq Biotechnology ETF (IBB) has a volatility of 5.77%. This indicates that XLV experiences smaller price fluctuations and is considered to be less risky than IBB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.